Trials / Unknown
UnknownNCT05340829
Evaluate the Safety and Effect of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/Lympholeukemia
To Evaluate the Safety, Efficacy, Pharmacokinetics of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/Lympholeukemia
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- He Huang · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label, phase I study to assess the safety and efficacy of ThisCART19A in patients with AIDS related B cell lymphoma/lympholeukemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ThisCART19A | ThisCART19A is a new type CAR-T cells therapy for patients with lymphoma and lympholeukemia |
Timeline
- Start date
- 2022-03-18
- Primary completion
- 2024-03-30
- Completion
- 2024-04-30
- First posted
- 2022-04-22
- Last updated
- 2022-04-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05340829. Inclusion in this directory is not an endorsement.